Dr Mark Kris continues the discussion on 5-year outcomes of neoadjuvant chemotherapy plus nivolumab in lung cancer, highlighting its curative potential and next steps.

Rachel Feltman: For Scientific American’s Science Quickly, I’m Rachel Feltman. Lung cancer is the deadliest cancer among women in the United States, surpassing the mortality numbers of breast and ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up their immune systems to help fight tumors. People with advanced lung or skin cancer who were ...

The Texas-based company announced on Tuesday that its research collaborators will present preclinical data at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer ...

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, ...

President Trump has been a cheerleader for coal miners. But these miners say his administration is failing to enforce limits on a lethal workplace hazard. Gary Hairston, 71, is a retired coal miner ...

Alex Kingston, known for her roles on hit shows like "ER" and "Doctor Who," revealed her battle with uterine cancer in a recent interview. In the first sign that something was wrong, the actress began ...

Treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly ...

Get a breath of this not-so-fresh air. Japanese and US researchers have developed a groundbreaking treatment for people who can’t breathe through their lungs — by delivering oxygen where the sun doesn ...

Angus Chen covers all issues broadly related to cancer including drugs, policy, science, and equity. He joined STAT in 2021 after covering health and science at NPR and NPR affiliate stations. His ...